In fact, high-profile examples of payers pulling back on coverage are stacking up: North Carolinas state health plan dropped GLP-1s after spending $100 million, Ascension eliminated all weight-loss drug coverage, and Mayo Clinic capped lifetime GLP-1 benefits at $20,000
Other less common side effects can include pancreatitis, gastroparesis, bowel obstruction, gallstones, blockage of the bile duct and risk of acute kidney injury
In Jan of 2021, I began taking BPC-157
What Published Mechanism Research Implies (And Doesn't) GHK-Cu's documented activities stimulating fibroblast proliferation, modulating collagen and glycosaminoglycan synthesis, affecting gene expression at scale (Pickart & Margolina describe an effect on roughly 31% of human genes, PMID 29986520) are mechanism findings, not adverse-event predictions
What documentation ships with each lot of the research-grade Ipamorelin peptide
In addition to their diagnostic potential, these novel metabolic alterations offer insights into Long COVID pathophysiology
